EUVIMEDEUVIMED entdecken
Crossref

Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer

Naoto Hoshino, Kensuke Yoshida, Yoshitomi Kanemitsu, Akira Toyama, Munetoshi Sugiura

Anticancer Research · 2026

DOI: 10.21873/anticanres.17941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Naoto Hoshino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Cisplatin, Uterine Cervical Neoplasms, Glomerular Filtration Rate, Antineoplastic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Toxicity-related discontinuation remains problematic in cisplatin-based cervical cancer treatment. This study aimed to evaluate the association between renal function assessed using individualized estimated glomerular filtration rate (eGFR) and the completion rate of cisplatin-based concurrent chemoradiotherapy (CCRT) in patients with cervical cancer. PATIENTS AND METHODS: This retrospective study included patients with cervical cancer who received CCRT with cisplatin (40 mg/m2/week, six cycles) at our institution between April 2015 and March 2024. Exclusion criteria included a Cockcroft-Gault-estimated creatinine clearance rate (CGCCr)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinUterine Cervical NeoplasmsGlomerular Filtration RateAntineoplastic AgentsKidneyHumansFemaleMiddle AgedRetrospective StudiesAgedAdultChemoradiotherapy

Stichwörter der Autor:innen

Cervical cancerchemoradiotherapycisplatin-basedindividualized eGFRrenal function assessment

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Division of Hospital Pharmacy, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan; msugi@toyaku.ac.jp.

Zitieren

APA

Hoshino, N., Yoshida, K., Kanemitsu, Y., Toyama, A., & Sugiura, M. (2026). Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17941

Vancouver

Hoshino N, Yoshida K, Kanemitsu Y, Toyama A, Sugiura M. Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.17941

BibTeX
@article{Hoshino2026,
  author = {Hoshino, Naoto and Yoshida, Kensuke and Kanemitsu, Yoshitomi and Toyama, Akira and Sugiura, Munetoshi},
  title = {Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17941}
}
Kostenlos starten →